Could Wegovy Raise Optic Nerve Risk? - Top_Thought_Leaders - MDSpire

Could Wegovy Raise Optic Nerve Risk?

A pharmacovigilance analysis of FDA adverse event reports finds the strongest ischemic optic neuropathy reporting signal with high-dose semaglutide formulations, with higher adjusted odds reported in men.

  • By

  • Kerri Miller

  • March 11, 2026

  • 5 min

Share

Top Thought Leaders in Ophthalmology

Brief introduction explaining scope and methodology.

Original Source(s)

Could Wegovy Raise Optic Nerve Risk?

  • by Kerri Miller

  • March 11, 2026

Related Content

Clinical Case Study: Post-Surgical Antiviral Intervention Following Pterygium Excision Informed by Corneal Confocal Microscopy

What RVO May Reveal About Systemic Health

TriNetX data presented at Retina World Congress linked BRVO and CRVO with increased risks of stroke, myocardial infarction, and carotid disease.

Equal Pay in Ophthalmology? Not Yet

A decade of AAMC salary data reveals a persistent gender pay gap in academic ophthalmology—and projects it will never close at senior ranks